Day: November 12, 2020

Firm Capital Property Trust Announces Solid Third Quarter Results

TORONTO, Nov. 12, 2020 (GLOBE NEWSWIRE) — Firm Capital Property Trust (“FCPT” or the “Trust”), (TSXV: FCD.UN) is pleased to report today its financial results for the three and nine months ended September 30, 2020.PROPERTY PORTFOLIO HIGHLIGHTSThe portfolio consists of 76 commercial properties with a total GLA of 4,244,849 square feet (2,350,850 square feet on an owned interest basis) and interests in two apartment complexes comprised of 204 apartment units. The portfolio is well diversified and defensive in terms of geographies and property asset types, with 59% of NOI comprised of grocery anchored retail followed by industrial at 22% of NOI.TENANT DIVERSIFICATIONThe portfolio is well diversified by tenant profile with no tenant accounting for more than 11.6% of total net rent. Further, the top 10 tenants are comprised of large...

Continue reading

Timber Pharmaceuticals Provides Business Update and Announces Third Quarter 2020 Financial Results

WOODCLIFF LAKE, NJ, Nov. 12, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Timber Pharmaceuticals, Inc. (“Timber” or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today provided a business update and announced financial results for the third quarter of 2020, ended September 30, 2020. John Koconis, Chief Executive Officer of Timber, commented, “During the third quarter the management team of Timber has been working hard on all fronts of the Company’s operations. This includes advancing our two ongoing Phase 2b clinical trials for orphan indications, exploring strategic options for the two assets acquired from BioPharmX Corp, and investigating options to improve the capital structure of the Company....

Continue reading

First Majestic to Appeal Circuit Court Decision to Nullify APA

VANCOUVER, British Columbia, Nov. 12, 2020 (GLOBE NEWSWIRE) — First Majestic Silver Corp. (“First Majestic” or the “Company”) announced today that its Mexican subsidiary Primero Empresa Minera, S.A. de C.V. (“PEM”) has now been provided with written reasons for the decision made on September 23, 2020 by the Mexican Federal Court on Administrative Matters (“Federal Court”), nullifying the Advance Pricing Agreement (“APA”) concluded in 2012 between PEM and the Mexican tax authority, Servicio de Administracion Tributaria (“SAT”).The Federal Court’s decision directs SAT to re-examine the evidence and basis for the issuance of the APA with retroactive effect, for the following key reasons (i) SAT’s errors in analyzing PEM’s request for the APA and the evidence provided in support of the request; and (ii) SAT’s...

Continue reading

Cassava Sciences Announces Proposed Public Offering of Common Stock

AUSTIN, Texas, Nov. 12, 2020 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA) (the “Company” or “Cassava Sciences”), a clinical-stage biotechnology company focused on Alzheimer’s disease, today announced that it is commencing an underwritten public offering of shares of its common stock. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or the actual size or terms of the offering. The Company expects to grant the underwriters a 30‐day option to purchase up to an additional 15 percent of the shares of common stock offered in the public offering.Cantor Fitzgerald & Co. is acting as sole book-running manager for the proposed offering.Cassava Sciences intends to use the net proceeds, if any, from the sale of the shares of common stock...

Continue reading

Guardian Capital Group Limited (TSX: GCG; GCG.A) Announces 2020 Third Quarter Operating Results

TORONTO, Nov. 12, 2020 (GLOBE NEWSWIRE) —All per share figures disclosed below are stated on a diluted basis.The Company is reporting Operating earnings of $12.1 million for the quarter ended September 30, 2020, substantially unchanged from the $12.1 million reported in the third quarter of 2019.The Net revenue for the current quarter grew to $52.0 million, $6.0 million or 13% higher than the $46.0 million reported in the same quarter in the prior year. Excluding the revenue contributions of $2.0 million from Aurrea Signature Inc. (“Aurrea”), and Modern Advisor Canada Inc. (“Modern Advisor”), two businesses which were acquired subsequent to the third quarter of 2019, the growth in Net revenue was $3.0 million. This organic growth was largely driven by growth in Guardcap Investment Management (“GuardCap”), the UK investment management...

Continue reading

Partners Bancorp Announces Stock Purchase Plan

SALISBURY, Md., Nov. 12, 2020 (GLOBE NEWSWIRE) — Partners Bancorp (NASDAQ: PTRS) (the “Company”), the parent company of The Bank of Delmarva (“Delmarva”), Seaford, Delaware, and Virginia Partners Bank (“Virginia Partners”), Fredericksburg, Virginia, announced today that its Board of Directors has approved a stock purchase plan. Under the plan, the Company is authorized to purchase up to 356,000 outstanding shares of its common stock. The Company may repurchase shares in the open market or through privately negotiated transactions.Lloyd B. Harrison, III, the Company’s Chief Executive Officer, commented, “We consider this to be in the best interests of the Company as it may be expected to improve the Company’s operating performance on a per share basis and enhance, in the long term, the market price per share of the Company’s common...

Continue reading

Roper Technologies Increases Dividend 10% – Its 28th Consecutive Annual Dividend Increase

SARASOTA, Fla., Nov. 12, 2020 (GLOBE NEWSWIRE) — Roper Technologies, Inc. (NYSE: ROP) announced today that its Board of Directors has declared a quarterly cash dividend of $0.5625 per share, payable on January 22, 2021 to stockholders of record as of January 8, 2021. This represents an increase of 10% over the dividend paid in each quarter of 2020, or an expected $0.20 increase on an annual basis ($0.05 on a quarterly basis).  This is the twenty-eighth consecutive year in which Roper has increased its dividend. About Roper TechnologiesRoper Technologies is a constituent of the S&P 500, Fortune 1000, and the Russell 1000 indices. Roper operates businesses that design and develop software (both license and software-as-a-service) and engineered products and solutions for a variety of niche end markets. Additional information about...

Continue reading

GCC Obtained a Favorable Resolution in the Annulment of the Damages Award, All Legal Proceedings in Bolivia Have Been Exhausted

CHIHUAHUA, Mexico, Nov. 12, 2020 (GLOBE NEWSWIRE) — Grupo Cementos de Chihuahua, S.A.B. de C.V. (BMV: GCC*, or “the Company”), a leading producer of cement and concrete in the United States and Mexico, announced today that it has obtained a favorable resolution in the annulment of the “Damages Award”, in the arbitration process commenced by Compañía de Inversiones Mercantiles, S.A. (“CIMSA”), against the Company and pursuant to the Inter-American Commission on International Commercial Arbitration.This annulment was notified by the highest constitutional justice authority in Bolivia on October 29th of this year. Consequently, all legal proceedings filed in the country of Bolivia have been resolved in favor of GCC.Based on this resolution, the Company will commence the corresponding legal proceedings in the United States to reverse...

Continue reading

T2 Biosystems to Participate in the Canaccord Genuity Virtual MedTech & Diagnostics Forum

LEXINGTON, Mass., Nov. 12, 2020 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that the Company plans to participate in the upcoming Canaccord Genuity Virtual MedTech & Diagnostics Forum.Management is scheduled to present Thursday, November 19, 2020 at 2:30pm ET. Interested parties may access a live and recorded webcast of the presentation on the “Investors” section of the Company’s website at www.t2biosystems.com.About T2 BiosystemsT2 Biosystems, a leader in the rapid detection of sepsis-causing pathogens, is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. T2 Biosystems’ products include the T2Dx® Instrument, T2Candida® Panel, the T2Bacteria® Panel,...

Continue reading

Tonix Pharmaceuticals Outlines New Statistical Method to Analyze Future PTSD Studies at the 3rd Annual Neuropsychiatric Drug Development Summit

Increasing Placebo Responses in PTSD Drug Trials Raise Questions About Current Methods of Measuring or Analyzing PTSD Symptom Change Over TimeThe U.S. 21st Century Cures Act Provides Direction on New Statistical Analyses Using SimulationsTonix Plans to Study TNX-102 SL in a New Phase 3 PTSD Trial in KenyaCHATHAM, N.J., Nov. 12, 2020 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that Seth Lederman, M.D., President and Chief Executive Officer of Tonix Pharmaceuticals, outlined a new statistical method to analyze future Posttraumatic Stress Disorder (PTSD) drug studies and presented a retrospective analysis using the new method of the Phase 3 HONOR study (P301) of TNX-102 SL (cyclobenzaprine HCl sublingual tablets), for the treatment...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.